Investigating the role of the immune system in Alzheimer's disease

Neuroimmune Genomic Profiling of Alzheimer's Disease

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10814621

This study is looking at how certain immune cells called T-cells might play a role in the progression of Alzheimer's disease, and it's for people with Alzheimer's who want to understand more about how their immune system interacts with the condition.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10814621 on NIH RePORTER

What this research studies

This research explores how the adaptive immune system interacts with Alzheimer's disease, particularly focusing on specific types of T-cells that may contribute to the disease's progression. By analyzing the genetic profiles of these immune cells in patients with Alzheimer's, the study aims to uncover the molecular mechanisms behind the disease's pathology. The researchers will utilize advanced assays to track T-cell receptor repertoires in both Alzheimer's patients and healthy controls, providing insights into the immune response in the aging brain.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at high risk for developing the condition.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies targeting the immune system to slow or prevent the progression of Alzheimer's disease.

How similar studies have performed: While the role of the immune system in Alzheimer's is a relatively new area of investigation, preliminary studies have shown promising results in understanding its impact on disease progression.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's Disease Pathway
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.